{"id":"https://openalex.org/W2002091306","doi":"https://doi.org/10.1097/00005053-199306000-00004","title":"Buprenorphine versus Methadone Maintenance for Opioid Dependence","display_name":"Buprenorphine versus Methadone Maintenance for Opioid Dependence","alternate_titles":[],"publication_year":1993,"publication_date":"1993-06-01","ids":{"openalex":"https://openalex.org/W2002091306","doi":"https://doi.org/10.1097/00005053-199306000-00004","mag":"2002091306","pmid":"https://pubmed.ncbi.nlm.nih.gov/8501457"},"language":"en","primary_location":{"id":"doi:10.1097/00005053-199306000-00004","doi":"https://doi.org/10.1097/00005053-199306000-00004","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00005053-199306000-00004","pdf_url":null,"source":{"id":"https://openalex.org/S13566964","display_name":"The Journal of Nervous and Mental Disease","issn_l":"0022-3018","issn":["0022-3018","1539-736X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Nervous and Mental Disease","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2002091306"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5071214414","display_name":"Thomas R. Kosten","orcid":"https://orcid.org/0000-0003-1505-555X","observed_orcids":["https://orcid.org/0000-0003-1505-555X"]},"institutions":[{"id":"https://openalex.org/I32971472","display_name":"Yale University","ror":"https://ror.org/03v76x132","country_code":"US","type":"education","lineage":["https://openalex.org/I32971472"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"THOMAS R. KOSTEN","raw_affiliation_strings":["Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut 06519","Substance Abuse Research Center, Department of Psychiatry, Yale University School of Medicine, 27 Sylvan Avenue, New Haven, Connecticut, 06519"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut 06519","institution_ids":["https://openalex.org/I32971472"]},{"raw_affiliation_string":"Substance Abuse Research Center, Department of Psychiatry, Yale University School of Medicine, 27 Sylvan Avenue, New Haven, Connecticut, 06519","institution_ids":["https://openalex.org/I32971472"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041094306","display_name":"Richard S. Schottenfeld","orcid":"https://orcid.org/0000-0002-8601-0394","observed_orcids":["https://orcid.org/0000-0002-8601-0394"]},"institutions":[{"id":"https://openalex.org/I32971472","display_name":"Yale University","ror":"https://ror.org/03v76x132","country_code":"US","type":"education","lineage":["https://openalex.org/I32971472"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"RICHARD SCHOTTENFELD","raw_affiliation_strings":["Substance Abuse Research Center, Department of Psychiatry, Yale University School of Medicine, 27 Sylvan Avenue, New Haven, Connecticut, 06519"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Substance Abuse Research Center, Department of Psychiatry, Yale University School of Medicine, 27 Sylvan Avenue, New Haven, Connecticut, 06519","institution_ids":["https://openalex.org/I32971472"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008522317","display_name":"Douglas M. Ziedonis","orcid":"https://orcid.org/0009-0000-2823-3066","observed_orcids":["https://orcid.org/0009-0000-2823-3066"]},"institutions":[{"id":"https://openalex.org/I32971472","display_name":"Yale University","ror":"https://ror.org/03v76x132","country_code":"US","type":"education","lineage":["https://openalex.org/I32971472"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"DOUGLAS ZIEDONIS","raw_affiliation_strings":["Substance Abuse Research Center, Department of Psychiatry, Yale University School of Medicine, 27 Sylvan Avenue, New Haven, Connecticut, 06519"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Substance Abuse Research Center, Department of Psychiatry, Yale University School of Medicine, 27 Sylvan Avenue, New Haven, Connecticut, 06519","institution_ids":["https://openalex.org/I32971472"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5091721666","display_name":"Jean Falcioni","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I32971472","display_name":"Yale University","ror":"https://ror.org/03v76x132","country_code":"US","type":"education","lineage":["https://openalex.org/I32971472"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"JEAN FALCIONI","raw_affiliation_strings":["Substance Abuse Research Center, Department of Psychiatry, Yale University School of Medicine, 27 Sylvan Avenue, New Haven, Connecticut, 06519"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Substance Abuse Research Center, Department of Psychiatry, Yale University School of Medicine, 27 Sylvan Avenue, New Haven, Connecticut, 06519","institution_ids":["https://openalex.org/I32971472"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I32971472"],"apc_list":null,"apc_paid":null,"fwci":18.3458,"has_fulltext":false,"cited_by_count":283,"citation_normalized_percentile":{"value":0.99490496,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":92,"max":98},"biblio":{"volume":"181","issue":"6","first_page":"358","last_page":"364"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10576","display_name":"Opioid Use Disorder Treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10576","display_name":"Opioid Use Disorder Treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10043","display_name":"Substance Abuse Treatment and Outcomes","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11199","display_name":"Pain Management and Opioid Use","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2703","display_name":"Anesthesiology and Pain Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/buprenorphine","display_name":"buprenorphine","score":0.9890000224113464},{"id":"https://openalex.org/keywords/methadone","display_name":"methadone","score":0.9779999852180481},{"id":"https://openalex.org/keywords/opioid-use-disorder","display_name":"opioid use disorder","score":0.9789999723434448},{"id":"https://openalex.org/keywords/opioid-maintenance-treatment","display_name":"opioid maintenance treatment","score":0.7170000076293945},{"id":"https://openalex.org/keywords/heroin-use","display_name":"heroin use","score":0.7229999899864197},{"id":"https://openalex.org/keywords/opioid-withdrawal-symptoms","display_name":"opioid withdrawal symptoms","score":0.6620000004768372},{"id":"https://openalex.org/keywords/treatment-retention","display_name":"treatment retention","score":0.949999988079071},{"id":"https://openalex.org/keywords/opioid-abstinence","display_name":"opioid abstinence","score":0.6909999847412109},{"id":"https://openalex.org/keywords/dose-comparison","display_name":"dose comparison","score":0.5730000138282776}],"concepts":[{"id":"https://openalex.org/C2778949969","wikidata":"https://www.wikidata.org/wiki/Q407721","display_name":"Buprenorphine","level":4,"score":0.9795897006988525},{"id":"https://openalex.org/C2778767360","wikidata":"https://www.wikidata.org/wiki/Q179996","display_name":"Methadone","level":2,"score":0.9325497150421143},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7596237063407898},{"id":"https://openalex.org/C2781063702","wikidata":"https://www.wikidata.org/wiki/Q427523","display_name":"Opioid","level":3,"score":0.6794211268424988},{"id":"https://openalex.org/C2778903686","wikidata":"https://www.wikidata.org/wiki/Q60168","display_name":"Heroin","level":3,"score":0.6205735206604004},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.5964450836181641},{"id":"https://openalex.org/C2779418921","wikidata":"https://www.wikidata.org/wiki/Q1639178","display_name":"Opioid use disorder","level":4,"score":0.5009257793426514},{"id":"https://openalex.org/C2778903061","wikidata":"https://www.wikidata.org/wiki/Q17156814","display_name":"Methadone maintenance","level":3,"score":0.48315900564193726},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2135220766067505},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.17426735162734985},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.1374572515487671},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002047","descriptor_name":"Buprenorphine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D002047","descriptor_name":"Buprenorphine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006556","descriptor_name":"Heroin Dependence","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D006556","descriptor_name":"Heroin Dependence","qualifier_ui":"Q000534","qualifier_name":"rehabilitation","is_major_topic":false},{"descriptor_ui":"D006556","descriptor_name":"Heroin Dependence","qualifier_ui":"Q000652","qualifier_name":"urine","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008691","descriptor_name":"Methadone","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D008691","descriptor_name":"Methadone","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D009293","descriptor_name":"Opioid-Related Disorders","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D009293","descriptor_name":"Opioid-Related Disorders","qualifier_ui":"Q000534","qualifier_name":"rehabilitation","is_major_topic":true},{"descriptor_ui":"D009293","descriptor_name":"Opioid-Related Disorders","qualifier_ui":"Q000652","qualifier_name":"urine","is_major_topic":false},{"descriptor_ui":"D015813","descriptor_name":"Substance Abuse Detection","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1097/00005053-199306000-00004","doi":"https://doi.org/10.1097/00005053-199306000-00004","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00005053-199306000-00004","pdf_url":null,"source":{"id":"https://openalex.org/S13566964","display_name":"The Journal of Nervous and Mental Disease","issn_l":"0022-3018","issn":["0022-3018","1539-736X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Nervous and Mental Disease","raw_type":"journal-article"},{"id":"pmid:8501457","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8501457","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of nervous and mental disease","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G2545340120","display_name":"CLINICAL RESEARCH CENTER FOR OPIOID AND COCAINE ABUSE","funder_award_id":"P50DA004060","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"},{"id":"https://openalex.org/G5661517870","display_name":"REDUCING AIDS RISKS","funder_award_id":"R18DA006190","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"},{"id":"https://openalex.org/G7814530213","display_name":"Pharmacotherapy for opioid and cocaine dependence","funder_award_id":"R01DA005626","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"}],"funders":[{"id":"https://openalex.org/F4320337347","display_name":"National Institute on Drug Abuse","ror":"https://ror.org/00fq5cm18"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2112174894","https://openalex.org/W1973849525","https://openalex.org/W1979184030","https://openalex.org/W4245487921","https://openalex.org/W2049676905","https://openalex.org/W2017627129","https://openalex.org/W1981968038","https://openalex.org/W1980315117","https://openalex.org/W2621160284","https://openalex.org/W2149717129"],"abstract_inverted_index":{"Buprenorphine":[0],"at":[1,12,73,77,165,231],"2":[2,36,74,111,138,145,166],"mg":[3,6,14,17,30,37,75,79,146,167],"and":[4,15,108,134,159,171,187,218],"6":[5,29,78,106,132,152],"daily":[7],"was":[8,71,182,204,209,235],"compared":[9],"with":[10,156,184],"methadone":[11,201,213,219,240],"35":[13,102,128],"65":[16,98,124],"during":[18],"24":[19],"weeks":[20,234],"of":[21,31,38,80,83,89,114,147,153,161],"maintenance":[22],"among":[23],"125":[24],"opioid-dependent":[25],"patients.":[26],"As":[27],"hypothesized,":[28],"buprenorphine":[32,39,81,148,164,196,242],"were":[33],"superior":[34],"to":[35,95,121,200],"in":[40,59,202],"reducing":[41],"illicit":[42,54],"opioid":[43,55,179,189],"use,":[44],"but":[45,62],"higher":[46],"dosage":[47],"did":[48],"not":[49,205],"improve":[50],"treatment":[51],"retention.":[52],"Self-reported":[53],"use":[56,115,162],"declined":[57],"substantially":[58],"all":[60],"groups,":[61],"by":[63],"the":[64,154,174],"third":[65],"month,":[66],"significantly":[67,185,210,222],"more":[68,223,237],"heroin":[69],"abuse":[70,180],"reported":[72],"than":[76,241],"or":[82],"methadone.":[84],"From":[85],"an":[86],"initial":[87],"average":[88],"$1860/month,":[90],"month":[91,151],"3":[92,233],"usage":[93],"dropped":[94,117],"$41":[96],"(methadone":[97,101,123,127],"mg),":[99,103,107,125,129,133],"$73":[100],"$118":[104],"(buprenorphine":[105,110,131,137],"$351/month":[109],"mg).":[112,139],"Days":[113],"also":[116,181,236],"from":[118],"29":[119],"days":[120],"1.7":[122],"2.8":[126],"4.0":[130],"6.6":[135],"days/month":[136,158,170],"This":[140],"relatively":[141],"low":[142],"efficacy":[143],"for":[144,163,173,230],"persisted":[149],"through":[150],"trial,":[155],"7.2":[157],"$235/month":[160],"versus":[168],"1.9":[169],"$65/month":[172],"other":[175],"three":[176],"groups.":[177],"Increased":[178],"associated":[183],"greater":[186],"persistent":[188],"withdrawal":[190],"symptoms.":[191],"Our":[192],"secondary":[193],"hypothesis,":[194],"that":[195],"would":[197],"be":[198],"equivalent":[199],"efficacy,":[203],"supported.":[206],"Treatment":[207],"retention":[208],"better":[211],"on":[212,239],"(20":[214],"vs.":[215,227,244],"16":[216],"weeks),":[217],"patients":[220],"had":[221],"opioid-free":[224],"urines":[225],"(51%":[226],"26%).":[228],"Abstinence":[229],"least":[232],"common":[238],"(65%":[243],"27%).(ABSTRACT":[245],"TRUNCATED":[246],"AT":[247],"250":[248],"WORDS)":[249]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2002091306","counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":6},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":5},{"year":2015,"cited_by_count":5},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":5},{"year":2012,"cited_by_count":7}],"updated_date":"2026-11-19T14:11:59.513116","created_date":"2016-06-24T00:00:00"}
